News

Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

3 hours ago in Entertainment

Today in entertainment history: May 5

musichall

A look back at the Hollywood headlines from years past.

15 hours ago in Entertainment

REVIEW: In-fighting is entertaining in ‘Captain America: Civil War’

13-overlay

"Civil War" stands out as certainly the biggest of the stand-alones, and among the best because of what it has in common with the better films in the Marvel universe: the conflict is deeply human, told humorously, and best enjoyed if you don't overthink it.

17 hours ago in Music

Roger Daltrey gets his own bubbly

rogerdaltrey386399512082

The Who frontman is releasing his own brand of champagne.